Imara Inc.

📍 Boston, United States🗓 Founded 2016👥 13 employees💰 Last funded Mar 2019
Biotechnology Research🌐 enliventherapeutics.com
Website LinkedIn
In February, 2023 Imara merged with Enliven therapeutics (ELVN), with the resulting firm retaining Enliven’s name and development pipeline. Enliven is a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors to help patients with cancer live not only longer, but better.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Imara Inc.?
Imara Inc. has 1 investors on record on gritt.io, 1 mid-stage.
When did Imara Inc. last raise funding?
The most recent investment in Imara Inc. recorded on gritt.io was in March 2019.
When was Imara Inc. founded?
Imara Inc. was founded in 2016.
What industry is Imara Inc. in?
Imara Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Imara Inc. based?
Imara Inc. is headquartered in Boston, United States.